Skip to main content


PLANO, TX, August 18, 2022 /PRNewswire/ — Bimini Health Tech (“Bimini” or the “Company”), a diversified medical device and regenerative therapy company, today announced that it will directly launch the Dermapose® Fat removal and transfer system, including the Dermapose Access and the Dermapose Refresh Microcalibration Syringe in the United States and Canada.

“The addition of Dermapose Access and Refresh to our growing Plastic and Reconstructive Surgery (PRS) portfolio strengthens Bimini’s position as the most comprehensive fat treatment portfolio on the market. Dermapose products complement other existing fat technologies from Bimini, Puregraft®Puregraft Boost® Adipose micronizer and Kerastem®a fat cell therapy treatment for alopecia that is currently in clinical development in United States,” said Brad ConlanCEO of Bimini Health Tech.

“Plastic surgery and other aesthetic procedures are moving towards more natural approaches such as autologous fat transfer. The demand for predictable, outcome-based technologies in this area has increased dramatically as consumers seek more natural.” Mr. Conlan continued, “Dermapose is a minimally invasive system that further eliminates the limitations associated with the adoption of fat transfer by allowing the physician to safely and consistently remove and treat the patient’s fatty tissue; and ensures that patient receives in-office natural fat grafting Bimini continues to deliver on its commitment to provide world-class technology to our physician partners and patients they can trust.

Dermapose is the latest cutting-edge technology in fat removal and transfer, dedicated to volumization and rejuvenation. Dermapose products are an all-in-one system designed to remove, purify, microsize and enable consistent reinjection of a patient’s own fat simply and elegantly in an office setting.

Learn more about Dermapose at and Bimini Health Tech at


Bimini Health Tech is a world leader in the medical aesthetics and regeneration market. The Bimini Health Tech portfolio includes Puregraft, Healeon, Dermapose and Kerastem. The company develops and markets innovative products that are elegant in their simplicity, yet impactful and proven in their aesthetic, reconstructive and therapeutic benefits. Since 2013, they have been developing innovative products to provide premium aesthetic and regenerative care options to consumers and physicians.

Dermapose Refresh is a suction lipoplasty system. The Dermapose Refresh is a sterile medical device intended for the closed-loop treatment of lipoaspirated tissue in medical procedures involving the harvesting, concentration and transfer of autologous adipose tissue harvested with a legally marketed lipoplasty system. The device is intended for use in the following surgical specialties when transfer of harvested adipose tissue is desired: orthopedic surgery, arthroscopic surgery, neurosurgery, gastrointestinal surgery and related organs, urological surgery, general surgery, gynecological surgery, thoracic surgery , laparoscopic surgery, and plastic and reconstructive surgery when aesthetic body remodeling is desired. Only legally marketed accessories, such as syringes, should be used with the system. If the harvested fat is to be transferred, the harvested fat should only be used without any additional handling. Consult the user instructions that accompany the product for important warnings, precautions and instructions.

Dermapose Access is a sterile, single-use system intended to facilitate the harvesting of autologous fat grafts from a patient for aesthetic body contouring. It creates a guided incision for the introduction of the cannula at a controlled depth (10 mm) under the skin with the aim of harvesting a small volume of adipose tissue.

SOURCE Bimini Health Tech